This work is licensed under the Creative Commons Attribution 4.0 International License.
Price M, Ballard C, Benedetti J, Neff C, Cioffi G, Waite KA, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2017-2021. Neuro Oncol 2024; 26(Suppl 6): vi1–85. doi: 10.1093/neuonc/noae145PriceMBallardCBenedettiJNeffCCioffiGWaiteKACBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2017-2021. Neuro Oncol2024; 26(Suppl 6): vi1–85. 10.1093/neuonc/noae145Open DOISearch in Google Scholar
Blumenthal DT, Won M, Mehta MP, Gilbert MR, Brown PD, Bokstein F, et al. Short delay in initiation of radiotherapy for patients with glioblastoma-effect of concurrent chemotherapy: a secondary analysis from the NRG Oncology/Radiation Therapy Oncology Group database. Neuro Oncol 2018; 20: 966-74. doi: 10.1093/neuonc/noy017BlumenthalDTWonMMehtaMPGilbertMRBrownPDBoksteinFShort delay in initiation of radiotherapy for patients with glioblastoma-effect of concurrent chemotherapy: a secondary analysis from the NRG Oncology/Radiation Therapy Oncology Group database. Neuro Oncol2018; 20: 966-74. 10.1093/neuonc/noy017Open DOISearch in Google Scholar
Waqar M, Trifiletti DM, McBain C, O’Connor J, Coope DJ, Akkari L, et al. Early therapeutic interventions for newly diagnosed glioblastoma: rationale and review of the literature. Curr Oncol Rep 2022; 24: 311-24. doi: 10.1007/s11912-021-01157-0WaqarMTrifilettiDMMcBainCO’ConnorJCoopeDJAkkariLEarly therapeutic interventions for newly diagnosed glioblastoma: rationale and review of the literature. Curr Oncol Rep2022; 24: 311-24. 10.1007/s11912-021-01157-0Open DOISearch in Google Scholar
Buszek SM, Al Feghali KA, Elhalawani H, Chevli N, Allen PK, Chung C. Optimal timing of radiotherapy following gross total or subtotal resection of glioblastoma: a real-world assessment using the National Cancer Database. Sci Rep 2020; 10: 4926. doi: 10.1038/s41598-020-61701-z.BuszekSMAl FeghaliKAElhalawaniHChevliNAllenPKChungC.Optimal timing of radiotherapy following gross total or subtotal resection of glioblastoma: a real-world assessment using the National Cancer Database. Sci Rep2020; 10: 4926. 10.1038/s41598-020-61701-z.Open DOISearch in Google Scholar
Zur I, Tzuk-Shina T, Guriel M, Eran A, Kaidar-Person O. Survival impact of the time gap between surgery and chemo-radiotherapy in Glioblastoma patients. Sci Rep 2020; 10: 9595. doi: 10.1038/s41598-020-66608-3.ZurITzuk-ShinaTGurielMEranAKaidar-PersonO.Survival impact of the time gap between surgery and chemo-radiotherapy in Glioblastoma patients. Sci Rep2020; 10: 9595. 10.1038/s41598-020-66608-3.Open DOISearch in Google Scholar
Li YM, Suki D, Hess K, Sawaya R. The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection? J Neurosurg 2016; 124: 977-88. doi: 10.3171/2015.5.JNS142087LiYMSukiDHessKSawayaR.The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?J Neurosurg2016; 124: 977-88. 10.3171/2015.5.JNS142087Open DOISearch in Google Scholar
Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005; 352: 987-96. doi: 10.1056/NEJMoa043330StuppRMasonWPvan den BentMJWellerMFisherBTaphoornMJBRadiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med2005; 352: 987-96. 10.1056/NEJMoa043330Open DOISearch in Google Scholar
Wen PY, van den Bent M, Youssef G, Cloughesy TF, Ellingson BM, Weller M, et al. RANO 2.0: Update to the response assessment in neuro-oncology criteria for high-and low-grade gliomas in adults. J Clin Oncol 2023; 41: 5187-99. doi: 10.1200/JCO.23.01059WenPYvan den BentMYoussefGCloughesyTFEllingsonBMWellerMRANO 2.0: Update to the response assessment in neuro-oncology criteria for high-and low-grade gliomas in adults. J Clin Oncol2023; 41: 5187-99. 10.1200/JCO.23.01059Open DOISearch in Google Scholar
Burnet NG, Jena R, Jefferies SJ, Stenning SP, Kirkby NF. Mathematical modelling of survival of glioblastoma patients suggests a role for radiotherapy dose escalation and predicts poorer outcome after delay to start treatment. Clin Oncol (R Coll Radiol) 2006; 18: 93-103. doi: 10.1016/j.clon.2005.08.017BurnetNGJenaRJefferiesSJStenningSPKirkbyNF.Mathematical modelling of survival of glioblastoma patients suggests a role for radiotherapy dose escalation and predicts poorer outcome after delay to start treatment. Clin Oncol (R Coll Radiol)2006; 18: 93-103. 10.1016/j.clon.2005.08.017Open DOISearch in Google Scholar
Irwin C, Hunn M, Purdie G, Hamilton D. Delay in radiotherapy shortens survival in patients with high grade glioma. J Neurooncol 2007; 85: 339-43. doi: 10.1007/s11060-007-9426-z.IrwinCHunnMPurdieGHamiltonD.Delay in radiotherapy shortens survival in patients with high grade glioma. J Neurooncol2007; 85: 339-43. 10.1007/s11060-007-9426-z.Open DOISearch in Google Scholar
Blumenthal DT, Won M, Mehta MP, Curran WJ, Souhami L, Michalski JM, et al. Short delay in initiation of radiotherapy may not affect outcome of patients with glioblastoma: a secondary analysis from the radiation therapy oncology group database. J Clin Oncol 2009; 27: 733-9. doi: 10.1200/JCO.2008.18.9035.BlumenthalDTWonMMehtaMPCurranWJSouhamiLMichalskiJMShort delay in initiation of radiotherapy may not affect outcome of patients with glioblastoma: a secondary analysis from the radiation therapy oncology group database. J Clin Oncol2009; 27: 733-9. 10.1200/JCO.2008.18.9035.Open DOISearch in Google Scholar
Nathan JK, Brezzell AL, Kim MM, Leung D, Wilkinson DA, Hervey-Jumper SL. Early initiation of chemoradiation following index craniotomy is associated with decreased survival in high-grade glioma. J Neurooncol 2017; 135: 325-33. doi: 10.1007/s11060-017-2577-7NathanJKBrezzellALKimMMLeungDWilkinsonDAHervey-JumperSL.Early initiation of chemoradiation following index craniotomy is associated with decreased survival in high-grade glioma. J Neurooncol2017; 135: 325-33. 10.1007/s11060-017-2577-7Open DOISearch in Google Scholar
Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol 2021; 23: 1231-51. doi: 10.1093/neuonc/noab106LouisDNPerryAWesselingPBratDJCreeIAFigarella-BrangerDThe 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol2021; 23: 1231-51. 10.1093/neuonc/noab106Open DOISearch in Google Scholar
Sharma M, McKenzie GW, Gaskins J, Yusuf M, Woo S, Mistry AM, et al. Demographic variations and time to initiation of adjunct treatment following surgical resection of anaplastic astrocytoma in the United States: a National Cancer Database analysis. J Neurooncol 2023; 162: 199-210. doi: 10.1007/s11060-023-04286-7SharmaMMcKenzieGWGaskinsJYusufMWooSMistryAMDemographic variations and time to initiation of adjunct treatment following surgical resection of anaplastic astrocytoma in the United States: a National Cancer Database analysis. J Neurooncol2023; 162: 199-210. 10.1007/s11060-023-04286-7Open DOISearch in Google Scholar
Zhang M, Xu F, Ni W, Qi W, Cao W, Xu C, et al. Survival impact of delaying postoperative chemoradiotherapy in newly-diagnosed glioblastoma patients. Transl Cancer Res 2020; 9: 5450-8. doi: 10.21037/tcr-20-1119ZhangMXuFNiWQiWCaoWXuCSurvival impact of delaying postoperative chemoradiotherapy in newly-diagnosed glioblastoma patients. Transl Cancer Res2020; 9: 5450-8. 10.21037/tcr-20-1119Open DOISearch in Google Scholar
Sun MZ, Oh T, Ivan ME, Clark AJ, Safaee M, Sayegh ET, et al. Survival impact of time to initiation of chemoradiotherapy after resection of newly diagnosed glioblastoma. J Neurosurg 2015; 122: 1144-50. doi: 10.3171/2014.9.JNS14193SunMZOhTIvanMEClarkAJSafaeeMSayeghETSurvival impact of time to initiation of chemoradiotherapy after resection of newly diagnosed glioblastoma. J Neurosurg2015; 122: 1144-50. 10.3171/2014.9.JNS14193Open DOISearch in Google Scholar
Press RH, Shafer SL, Jiang R, Buchwald ZS, Abugideiri M, Tian S, et al. Optimal timing of chemoradiotherapy after surgical resection of glioblastoma: stratification by validated prognostic classification. Cancer 2020; 126: 3255-64. doi: 10.1002/cncr.32797.PressRHShaferSLJiangRBuchwaldZSAbugideiriMTianSOptimal timing of chemoradiotherapy after surgical resection of glioblastoma: stratification by validated prognostic classification. Cancer2020; 126: 3255-64. 10.1002/cncr.32797.Open DOISearch in Google Scholar
Noel G, Huchet A, Feuvret L, Maire JP, Verrelle P, Le Rhun E, et al. Waiting times before initiation of radiotherapy might not affect outcomes for patients with glioblastoma: a French retrospective analysis of patients treated in the era of concomitant temozolomide and radiotherapy. J Neurooncol 2012; 109: 167-75. doi: 10.1007/s11060-012-0883-7.NoelGHuchetAFeuvretLMaireJPVerrellePLe RhunEWaiting times before initiation of radiotherapy might not affect outcomes for patients with glioblastoma: a French retrospective analysis of patients treated in the era of concomitant temozolomide and radiotherapy. J Neurooncol2012; 109: 167-75. 10.1007/s11060-012-0883-7.Open DOISearch in Google Scholar
Loureiro LVM, Pontes Lde B, Callegaro-Filho D, Koch Lde O, Weltman E, Victor Eda S, et al. Waiting time to radiotherapy as a prognostic factor for glioblastoma patients in a scenario of medical disparities. Arq Neuropsiquiatr 2015; 73: 104-10. doi: 10.1590/0004-282X20140202LoureiroLVMPontes LdeBCallegaro-FilhoDKoch LdeOWeltmanEVictor EdaSWaiting time to radiotherapy as a prognostic factor for glioblastoma patients in a scenario of medical disparities. Arq Neuropsiquiatr2015; 73: 104-10. 10.1590/0004-282X20140202Open DOISearch in Google Scholar
Wang TJC, Jani A, Estrada JP, Ung TH, Chow DS, Soun JE, et al. Timing of adjuvant radiotherapy in glioblastoma patients: a single-institution experience with more than 400 patients. Neurosurgery 2016; 78: 676-82. doi: 10.1227/NEU.0000000000001036WangTJCJaniAEstradaJPUngTHChowDSSounJETiming of adjuvant radiotherapy in glioblastoma patients: a single-institution experience with more than 400 patients. Neurosurgery2016; 78: 676-82. 10.1227/NEU.0000000000001036Open DOISearch in Google Scholar
Katsigiannis S, Krischek B, Barleanu S, Grau S, Galldiks N, Timmer M, et al. Impact of time to initiation of radiotherapy on survival after resection of newly diagnosed glioblastoma. Radiat Oncol 2019; 14: 73. doi: 10.1186/s13014-019-1272-6.KatsigiannisSKrischekBBarleanuSGrauSGalldiksNTimmerMImpact of time to initiation of radiotherapy on survival after resection of newly diagnosed glioblastoma. Radiat Oncol2019; 14: 73. 10.1186/s13014-019-1272-6.Open DOISearch in Google Scholar
Ahn S, Park JS, Song JH, Jeun SS, Hong YK. Effect of a time delay for concomitant chemoradiation after surgery for newly diagnosed glioblastoma: A single-institution study with subgroup analysis according to the extent of tumor resection. World Neurosurg 2020; 133: e640–5. doi: 10.1016/j.wneu.2019.09.122AhnSParkJSSongJHJeunSSHongYK.Effect of a time delay for concomitant chemoradiation after surgery for newly diagnosed glioblastoma: A single-institution study with subgroup analysis according to the extent of tumor resection. World Neurosurg2020; 133: e640–5. 10.1016/j.wneu.2019.09.122Open DOISearch in Google Scholar
Domènech M, Hernández A, Plaja A, Martínez-Balibrea E, Balañà C. Hypoxia: The cornerstone of glioblastoma. Int J Mol Sci 2021; 22: 12608. doi: 10.3390/ijms222212245DomènechMHernándezAPlajaAMartínez-BalibreaEBalañàC.Hypoxia: The cornerstone of glioblastoma. Int J Mol Sci2021; 22: 12608. 10.3390/ijms222212245Open DOISearch in Google Scholar
Murray D, Mirzayans R, Scott AL, Allalunis-Turner MJ. Influence of oxygen on the radiosensitivity of human glioma cell lines. Am J Clin Oncol 2003; 26: e169-77. doi: 10.1097/01.coc.0000091359.11281.f4MurrayDMirzayansRScottALAllalunis-TurnerMJ.Influence of oxygen on the radiosensitivity of human glioma cell lines. Am J Clin Oncol2003; 26: e169-77. 10.1097/01.coc.0000091359.11281.f4Open DOISearch in Google Scholar
Atalar B, Choi CYH, Harsh GR, Chang SD, Gibbs IC, Adler JR, et al. Cavity volume dynamics after resection of brain metastases and timing of postresection cavity stereotactic radiosurgery. Neurosurgery 2013; 72: 180-5; discussion 185. doi: 10.1227/NEU.0b013e31827b99f3AtalarBChoiCYHHarshGRChangSDGibbsICAdlerJRCavity volume dynamics after resection of brain metastases and timing of postresection cavity stereotactic radiosurgery. Neurosurgery2013; 72: 180-5; discussion 185. 10.1227/NEU.0b013e31827b99f3Open DOISearch in Google Scholar
Champ CE, Siglin J, Mishra M V, Shen X, Werner-Wasik M, Andrews DW, et al. Evaluating changes in radiation treatment volumes from post-operative to same-day planning MRI in High-grade gliomas. Radiat Oncol 2012; 7: 220. doi: 10.1186/1748-717x-7-220.ChampCESiglinJMishra MVShenXWerner-WasikMAndrewsDWEvaluating changes in radiation treatment volumes from post-operative to same-day planning MRI in High-grade gliomas. Radiat Oncol2012; 7: 220. 10.1186/1748-717x-7-220.Open DOISearch in Google Scholar
Peker S, Abacioglu U, Sun I, Yuksel M, Pamir MN. Irradiation after surgically induced brain injury in the rat: timing in relation to severity of radiation damage. J Neurooncol 2004; 70: 17-21. doi: 10.1023/b:neon.0000040820.78643.0aPekerSAbaciogluUSunIYukselMPamirMN.Irradiation after surgically induced brain injury in the rat: timing in relation to severity of radiation damage. J Neurooncol2004; 70: 17-21. 10.1023/b:neon.0000040820.78643.0aOpen DOISearch in Google Scholar
Randolph DM, McTyre ER, Paulsson AK, Holmes JA, Hinson WH, Lesser GJ, et al. Impact of timing of radiotherapy in patients with newly diagnosed glioblastoma. Clin Neurol Neurosurg 2016; 151: 73-8. doi: 10.1016/j.clineuro.2016.10.012RandolphDMMcTyreERPaulssonAKHolmesJAHinsonWHLesserGJImpact of timing of radiotherapy in patients with newly diagnosed glioblastoma. Clin Neurol Neurosurg2016; 151: 73-8. 10.1016/j.clineuro.2016.10.012Open DOISearch in Google Scholar
Gállego Pérez-Larraya J, Ducray F. Treating glioblastoma patients with poor performance status: where do we go from here? CNS Oncol 2014; 3: 231-41. doi: 10.2217/cns.14.20. Erratum in: CNS Oncol 2014; 3: 378. doi:10.2217/cns.14.20Gállego Pérez-LarrayaJDucrayF.Treating glioblastoma patients with poor performance status: where do we go from here?CNS Oncol2014; 3: 231-41. 10.2217/cns.14.20. Erratum in: CNS Oncol 2014; 3: 378. 10.2217/cns.14.20Open DOISearch in Google Scholar